Paper36980800
A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia.
Carbó JM and 10 others. Cancers (Basel), 2023. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia. Papers, record 36980800. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980800
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PRODUCTE | Agency for Administration of University and Research | PubMed | ||
| Caixaimpulse | Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona | PubMed | ||
| 201930-30 | Fundació Marató TV3 | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,293,397 | Selective killing of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts. | J Inherit Metab Dis | 1992 | https://conductscience.org/library/papers/1293397 | PubMed |
| 2 | 32,014,868 | Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges. | Cancer Discov | 2020 | https://conductscience.org/library/papers/32014868 | PubMed |
| 3 | 35,582,535 | Lysosome-mediated chemoresistance in acute myeloid leukemia. | Cancer Drug Resist | 2022 | https://conductscience.org/library/papers/35582535 | PubMed |
| 4 | 31,915,366 | Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse? | Leukemia | 2020 | https://conductscience.org/library/papers/31915366 | PubMed |
| 5 | 30,610,707 | Methods to Detect Loss of Lysosomal Membrane Integrity. | Methods Mol Biol | 2019 | https://conductscience.org/library/papers/30610707 | PubMed |
| 6 | 31,406,169 | Identification of a factor controlling lysosomal homeostasis using a novel lysosomal trafficking probe. | Sci Rep | 2019 | https://conductscience.org/library/papers/31406169 | PubMed |
| 7 | 33,634,751 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. | Autophagy | 2021 | https://conductscience.org/library/papers/33634751 | PubMed |
| 8 | 23,202,731 | Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23202731 | PubMed |
| 9 | 31,473,184 | Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells. | EBioMedicine | 2019 | https://conductscience.org/library/papers/31473184 | PubMed |
| 10 | 18,158,874 | Dynamic effects of autophagy on arsenic trioxide-induced death of human leukemia cell line HL60 cells. | Acta Pharmacol Sin | 2008 | https://conductscience.org/library/papers/18158874 | PubMed |
| 11 | 31,974,170 | Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia. | Cancer Discov | 2020 | https://conductscience.org/library/papers/31974170 | PubMed |
| 12 | 25,997,737 | Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies. | Mol Cells | 2015 | https://conductscience.org/library/papers/25997737 | PubMed |
| 13 | 22,094,260 | Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. | Cancer Cell | 2011 | https://conductscience.org/library/papers/22094260 | PubMed |
| 14 | 34,171,263 | The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance. | Cancer Cell | 2021 | https://conductscience.org/library/papers/34171263 | PubMed |
| 15 | 32,315,388 | FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia. | Blood | 2020 | https://conductscience.org/library/papers/32315388 | PubMed |
| 16 | 30,546,014 | Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/30546014 | PubMed |
| 17 | 32,700,072 | The Time Has Come for Targeted Therapies for AML: Lights and Shadows. | Oncol Ther | 2020 | https://conductscience.org/library/papers/32700072 | PubMed |
| 18 | 23,359,069 | Notch activation inhibits AML growth and survival: a potential therapeutic approach. | J Exp Med | 2013 | https://conductscience.org/library/papers/23359069 | PubMed |
| 19 | 35,323,341 | Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review. | Curr Oncol | 2022 | https://conductscience.org/library/papers/35323341 | PubMed |
| 20 | 29,420,223 | Oxidative Phosphorylation as an Emerging Target in Cancer Therapy. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29420223 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,027,232 | Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/39027232 | PubMed |
| 38,162,504 | Establishment of a lysosome-related prognostic signature in breast cancer to predict immune infiltration and therapy response. | Front Oncol | 2023 | https://conductscience.org/library/papers/38162504 | PubMed |
| 37,508,431 | Remodelling of the Mitochondrial Bioenergetic Pathways in Human Cultured Fibroblasts with Carbohydrates. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37508431 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36980800
GET https://conductscience.org/api/papers/v1/36980800/references?page=2